Nutrition in inflammatory bowel disease: Impact on disease and therapy

Current Opinion in Gastroenterology

Volumn 17, Issue 4, 2001, Pages 342-349

  Cabre E ^a   Gassull, M A ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; ANTIOXIDANT; BUDESONIDE; BUTYRIC ACID; COLLAGEN TYPE 1; CORTICOSTEROID; CYTOKINE; FENCLONINE; FISH OIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MESALAZINE; MESSENGER RNA; MINERAL; OLIVE OIL; PARATHYROID HORMONE; POLYUNSATURATED FATTY ACID; SEROTONIN; SHORT CHAIN FATTY ACID; SOMATOMEDIN C; STEROID; SULFUR DERIVATIVE; TRACE ELEMENT; TRANSFORMING GROWTH FACTOR BETA2; TRINITROBENZENESULFONIC ACID; VITAMIN;

ANTIINFLAMMATORY ACTIVITY; BONE MINERAL; CLINICAL TRIAL; CROHN DISEASE; DIETARY FIBER; DUAL ENERGY X RAY ABSORPTIOMETRY; ENTERIC FEEDING; ENTERITIS; FAT INTAKE; GROWTH RETARDATION; HUMAN; NONHUMAN; NUTRIENT; NUTRITION; OSTEOPENIA; PROTEIN CALORIE MALNUTRITION; REVIEW; RISK FACTOR;

EID: 0034935438     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200107000-00008     Document Type: Review

References (96)

1. Nutritional implications of inflammatory bowel disease
2. Protein-energy malnutrition in gastroenterology outpatients: Increased risk in Crohn's disease
3. Undernutrition in Crohn's disease: An anthropometric assessment
4. Enteral nutrition in inflammatory bowel disease
5. Comprehensive nutritional status in patients with long-standing Crohn's disease currently in remission
6. Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls
7. Experimental colitis and reduction of food intake: What are the mechanisms?
8. The role of medial hypothalamic serotonin in the supression of feeding in a rat model of colitis
9. Interleukin-1 augments the release of norepinephrine, dopamine, and serotonin in the rat hypothalamus
10. The metabolic impact of active ulcerative colitis: Energy expenditure and nitrogen balance
11. Resting and total energy expenditure in patients with inflammatory bowel disease
12. Energy expenditure and body composition in children with Crohn's disease: Effect of enteral nutrition and treatment with prednisolone
13. Total energy expenditure in patients with Crohn's disease: Measurement by the combined body scan technique
14. Estimated versus measured basal energy requirements in patients with Crohn's disease
15. Augmentation de la dépense énergétique de repos lots des poussées de la maladie de Crohn
16. Energy metabolism and substrate oxidation in patients with Crohn's disease
17. Elevated diet-induced thermogenesis and lipid oxidation rate in Crohn's disease
18. Energy and substrate metabolism in patients with active Crohn's disease
19. Growth and clinical course of children with Crohn's disease
20. Growth, body composition, and nutritional status in children and adolescents with Crohn's disease
21. Growth after intestinal resection for Crohn's disease in children, adolescents and young adults
22. Growth failure occurs through a decrease in insulin-like growth factor 1 with is independent of undernutrition in a rat model of colitis
23. Metabolic bone assessment in patients with inflammatory bowel disease
24. A controlled study of bone mineral density in patients with inflammatory bowel disease
25. Reduced bone density in patients with inflammatory bowel disease
26. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: A population based study
27. Decreased trabecular bone mineral density in newly diagnosed inflammatory bowel disease patients in Korea
28. Bone mineral density in patients with recently diagnosed inflammatory bone disease
29. Altered bone metabolism in inflammatory bowel disease: There is a difference between Crohn's disease and ulcerative colitis
30. Risk factors for low bone mineral density in children and young adults with Crohn's disease
31. Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease
32. The concept of borderline vitamin deficiency
33. Vitamin status in patients with inflammatory bowel disease
34. Multiple vitamin status in Crohn's disease: Correlation with disease activity
35. Serum zinc, copper, and selenium levels in inflammatory bowel disease: Effect of total enteral nutrition on trace element status
36. Serum selenium, copper, and zinc concentrations in Crohn's disease and ulcerative colitis
37. Altered plasma nad mucosal concentrations of trace-elements and antioxidants in active ulcerative colitis
38. Antioxidant and immune status in active Crohn's disease: A possible relationship
39. Microbial factors in chronic intestinal inflammation
40. Defining new pathogens and nonculturable infectious agents associated with inflammatory bowel disease
41. Pre-illness dietary factors in inflammatory bowel disease
42. Diet in the management of Crohn's disease
43. Treatment of active Crohn's disease by exclusion diet: East Anglian multicenter controlled trial
44. The composition of food consumed by Greenland Eskimos
45. Epidemiological studies in the Upernavik district, Greenland
46. Biochemical and cellular basis for potential therapeutic value of n-3 fatty acids derived from fish oil
47. Effect of (n-3) polyunsaturated fatty acids on cytokine production and their biologic function
48. Nutritional modulation of cytokine biology
49. Diet as a risk factor for the development of ulcerative colitis
50. The colonic epithelium in ulcerative colitis: An energy-deficient disease?
51. Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis
52. Short-chain fatty acids in ulcerative colitis
53. In vivo butyrate metabolism and colonic permeability in extensive ulcerative colitis
54. In vivo measurement of colonic butyrate metabolism in patients with quiescent ulcerative colitis
55. Reducing sulfur compounds of the colon impair colonocyte nutrition: Implications for ulcerative colitis
56. Hydrogen sulphide: A bacterial toxin in ulcerative colitis?
57. The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to fecal sulphide in patients with ulcerative colitis
58. The luminal short-chain fatty acid butyrate modulates NF-κB activity in a human colonic epithelial cell line
59. Butyrate inhibits inflammatory responses through NFκB inhibition: Implications for Crohn's disease
60. Elemental diet as primary treatment of acute Crohn's disease: A controlled trial
61. Enteral nutrition in inflammatory bowel disease
62. Dietary treatment of active Crohn's d sease: Fewer side effects but poorly tolerated and no more effective than corticosteroids
63. Critical appraisal of enteral nutrition as primary therapy in adults with Crohn's disease
64. How effective is enteral nutrition in inducing clinical remission in active Crohn's disease? A meta-analysis of the randomized clinical trials
65. Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease
66. Defined-formula diets versus steroids in the treatment of active Crohn's disease: A meta-analysis
67. National Cooperative Crohn's disease study: Results of drug treatment
68. Mesalamine capsules for the treatment of active Crohn's disease: Results of a 16-week trial
69. Oral budesonide for active Crohn's disease
70. A comparison of budesonide with prednisolone for active Crohn's disease
71. Oral budesonide is as effective as oral prednisolone in active Crohn's disease
72. Azathiopdne and 6-mercaptopurine in Crohn's disease: A meta-analysis
73. Chronic intermittent elemental diet improves growth failure in children with Crohn's disease
74. Home nocturnal supplemental nasogastric feedings in growth-retarded adolescents with Crohn's disease
75. Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children
76. Enteral nutrition: The neglected primary therapy of Crohn's disease
77. Supplementary enteral nutrition maintains remission in pediatric Crohn's disease
78. Cyclical exclusive semi-elemental diet therapy normalizes growth and decreases relapse rate in pediatric Crohn's disease
79. Enteral nutrition for Crohn's disease in Japan
80. Effects of elemental diet on surgical treatment in Crohn's disease
81. Polymeric versus elemental diet as primary treatment in active Crohn's disease: A randomized, double-blind trial
82. Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease
83. Enteral nutrition as primary therapy in Crohn's disease
84. Polymeric enteral diet as primary treatment of active Crohn's disease: A prospective steroid-controlled trial
85. Long-chain triglycerides reduce the efficacy of enteral feeds in patients with active Crohn's disease
86. Nutritional supplementation with n-3 fatty acids and antioxidants in patrients with Crohn's disease in remission: Effects on antioxidant status and fatty acid profile
87. Mucosal healing and a decrease in mucosal proinflammatory cytokine mRNA induced by a specific oral polymeric diet in pediatric Crohn's disease
88. The role of nutrition in the pathogenesis of inflammatory bowel disease
89. Comparison of ω-3 fatty acids and sulfasalazine in ulcerative colitis
90. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease
91. Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease: A randomized controlled multicenter trial
92. Polyunsaturated fatty acids and inflammatory bowel disease
93. Combined oral sodium butyrate and mesalazine treatment compared with oral mesalazine alone in ulcerative colitis: Randomized, double-blind, placebo-controlled pilot study
94. Randomized clinical trial of Plantago ovata (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis
95. Molecular cloning and expression of a pituitary gland protein modulating intestinal fluid secretion
96. Food induced stimulation of the antisecretory factor can improve symptoms in human inflammatory bowel disease: A study of a concept